Main Session
Sep
28
SS 23 - Emerging Pathways and Targeted Therapies
216 - Overcoming Myeloid-Driven Resistance of High-Grade Gliomas to CAR T Cell Therapy: Mechanistic Determinants and Therapeutic Targeting
Presenter(s)
Sharareh Gholamin, MD, PhD - City of Hope Comprehensive Cancer Center, Duarte, CA